{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.3616.200.110.102.4023",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2022-07-14T01:03:32.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.4023",
  "version": "20220714",
  "name": "COVID 19 Vaccination",
  "status": "active",
  "date": "2022-07-14T01:03:32-04:00",
  "publisher": "Clinical Architecture",
  "compose": {
    "include": [
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "concept": [
          {
            "code": "XW013S6",
            "display": "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW013T6",
            "display": "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW013U6",
            "display": "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW023S6",
            "display": "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW023T6",
            "display": "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW023U6",
            "display": "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:9173bfb3-3b3b-460f-8894-ec3c38f8f357",
    "timestamp": "2022-09-28T05:26:33-04:00",
    "total": 6,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "code": "XW013S6",
        "display": "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "code": "XW013T6",
        "display": "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "code": "XW013U6",
        "display": "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "code": "XW023S6",
        "display": "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "code": "XW023T6",
        "display": "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2023",
        "code": "XW023U6",
        "display": "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"
      }
    ]
  }
}